Advertisement
Screener

Palvella Therapeutics, Inc. (PVLA) Patents: Active

Palvella Therapeutics, Inc. Active Patents

22 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-05-01: Application 18310325; Invention ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE; Applicant PALVELLA THERAPEUTICS, INC.; Status Patented Case.
  • 2022-01-19: Application 17579392; Invention NOVEL PROTEINS SPECIFIC FOR CD137; Applicant Pieris Pharmaceuticals GmbH; Status Patented Case.
  • 2021-10-12: Application 17499640; Invention LIPOCALIN MUTEINS WITH BINDING AFFINITY FOR LAG-3; Applicant Pieris Pharmaceuticals GmbH; Status Patented Case.
  • 2021-08-31: Application 17462800; Invention ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE; Applicant PALVELLA THERAPEUTICS, INC.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2023-05-0118310325ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEPALVELLA THERAPEUTICS, INC.Patented Case2025-06-1712329748US20230263781A1
Wesley Harton KAUPINEN
Braham SHROOT
Simon David BETSON
Charles Rodney GREENAWAY EVANS
Marc Barry BROWN
United States
France
United Kingdom
United Kingdom
United Kingdom
HENLEY III, RAYMOND J
2022-01-1917579392NOVEL PROTEINS SPECIFIC FOR CD137Pieris Pharmaceuticals GmbHPatented Case2025-01-1412195503US20220144901A1
Marlon HINNER
Christine ROTHE
Shane OLWILL
Andrea ALLERSDORFER
Rachida Siham BEL AIBA
Germany
Germany
Germany
Germany
Germany
MARTINEZ, TARA L
2021-10-1217499640LIPOCALIN MUTEINS WITH BINDING AFFINITY FOR LAG-3Pieris Pharmaceuticals GmbHPatented Case2023-10-0311773147US20220098253A1
Christine Rothe
Shane Olwill
Andrea Allersdorfer
Timo Eichner
Rachida Siham Bel Aiba
Marina Pavlidou
Germany
Germany
Germany
Germany
Germany
Germany
BRADLEY, CHRISTINA
2021-08-3117462800ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEPALVELLA THERAPEUTICS, INC.Patented Case2025-04-0812268673US20220016089A1
Wesley Harton KAUPINEN
Braham SHROOT
Simon David BETSON
Charles Rodney GREENAWAY EVANS
Marc Barry BROWN
United States
France
United Kingdom
United Kingdom
United Kingdom
CHENG, KAREN
2021-08-2317433155Novel Fusion Proteins Specific for CD137 and GPC3Pieris Pharmaceuticals GmbHPatented Case2025-12-0212486330US20220153864A1
Rachida Siham BEL AIBA
Birgit BOSSENMAIER
Thomas JAQUIN
Janet PEPER-GABRIEL
Eva-Maria HANSBAUER
Corinna SCHLOSSER
Shane OLWILL
Germany
Germany
Germany
Germany
Germany
Germany
Germany
DUFFY, BRADLEY
2021-04-0717224799ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEPALVELLA THERAPEUTICS, INC.Patented Case2023-06-2011679101US20210244713A1
Wesley Harton KAUPINEN
Braham SHROOT
Simon David BETSON
Charles Rodney GREENAWAY EVANS
Marc Barry BROWN
United States
France
United Kingdom
United Kingdom
United Kingdom
HENLEY III, RAYMOND J
2021-02-0517169209ANTI-CANCER FUSION POLYPEPTIDE CAPABLE OF BINDING BOTH CD137 AND GLYPICAN-3 (GPC3)Pieris Pharmaceuticals GmbHPatented Case2024-03-0511919931US20210403516A1
Marlon Hinner
Rachida Siham Bel Aiba
Christine Rothe
Shane Olwill
Corinna Schlosser
Germany
Germany
Germany
Germany
Germany
LANDSMAN, ROBERT S
2020-06-1816905059ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEPALVELLA THERAPEUTICS, INC.Patented Case2021-10-0511135204US20200316034A1
Wesley Harton KAUPINEN
Braham SHROOT
Simon David BETSON
Charles Rodney GREENAWAY EVANS
Marc Barry BROWN
United States
France
United Kingdom
United Kingdom
United Kingdom
MATOS NEGRON, TAINA DEL MAR
2020-04-3016863907METHODS OF TREATING KERATIN HYPERPROLIFERATION DISORDERS USING mTOR INHIBITORSPALVELLA THERAPEUTICS, INC.Patented Case2023-04-0411617742US20200383956A1
Roger Louis Kaspar
Robyn Patricia Hickerson
United States
United States
SHTERENGARTS, SAMANTHA L
2020-03-0616812069MUTEINS OF HUMAN LIPOCALIN 2 (LCN2,HNGAL) WITH AFFINITY FOR A GIVEN TARGETPieris Pharmaceuticals GmbHPatented Case2023-11-2811827681US20200308237A1
Arne Skerra
Michaela Gebauer
Dominik Hinz
Sabine Rauth
Gabriele Matschiner
Martin Huelsmeyer
Germany
Germany
Germany
Germany
Germany
Germany
EPPS-SMITH, JANET L
2019-07-0216460125ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEPALVELLA THERAPEUTICS, INC.Patented Case2021-05-1111000513US20200000778A1
Wesley Harton Kaupinen
Braham Shroot
Simon David BETSON
Charles Rodney GREENAWAY EVANS
Marc Barry BROWN
United States
France
United Kingdom
United Kingdom
United Kingdom
HENLEY III, RAYMOND J
2018-01-1215744531MUTEINS OF HUMAN TEAR LIPOCALIN CAPABLE OF BINDING LYMPHOCYTE-ACTIVATION GENE 3 (LAG-3) AND METHODS OF USE THEREOFPIERIS PHARMACEUTICALS GMBHPatented Case2019-12-1010501510US20190031729A1
Christine ROTHE
Andrea ALLERSDORFER
Alexander WIEDENMANN
Rachida Siham BEL AIBA
Shane OLWILL
Timo EICHNER
Germany
Germany
Germany
Germany
Germany
Germany
LANDSMAN, ROBERT S
2018-01-0515863573ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USEPALVELLA THERAPEUTICS INCPatented Case2020-07-2810722499US20180193320A1
Wesley Harton KAUPINEN
Braham SHROOT
Simon David BETSON
Charles Rodney GREENAWAY EVANS
Marc Barry BROWN
United States
France
United Kingdom
United Kingdom
United Kingdom
MATOS NEGRON, TAINA DEL MAR
2017-11-1715575309ANTI-CANCER FUSION POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USING POLYPEPTIDESPieris Pharmaceuticals GmbHPatented Case2021-02-0910913778US20180148485A1
Marlon HINNER
Rachida Siham BEL AIBA
Christine ROTHE
Shane OLWILL
Corinna SCHLOSSER
Germany
Germany
Germany
Germany
Germany
LANDSMAN, ROBERT S
2017-11-1715575271MUTEINS OF HUMAN LIPOCALIN 2 WITH AFFINITY FOR GLYPICAN-3 (GPC3) AND METHODS OF USE THEREOFPieris Pharmaceuticals GmbHPatented Case2019-04-3010273275US20180141988A1
Marlon HINNER
Andrea ALLERSDORFER
Rachida Siham BEL AIBA
Michaela ALOE
Alexander WIEDENMANN
Gabriele MATSCHINER
Martin HUELSMEYER
Germany
Germany
Germany
Germany
Germany
Germany
France
LANDSMAN, ROBERT S
2017-11-0315571611NOVEL PROTEINS SPECIFIC FOR CD137Pieris Pharmaceuticals GmbHPatented Case2022-03-0111261221US20180148484A1
Marlon HINNER
Christine ROTHE
Shane OLWILL
Andrea ALLERSDORFER
Rachida Siham BEL AIBA
Germany
Germany
Germany
Germany
Germany
MARTINEZ, TARA L
2017-11-0315571561ANTI-CANCER FUSION POLYPEPTIDEPieris Pharmaceuticals GmbHPatented Case2020-12-1510865250US20190010248A1
Marlon HINNER
Christine ROTHE
Shane OLWILL
Rachida Siham BEL AIBA
Ulrich MOEBIUS
Corinna SCHLOSSER
Thomas Jean JAQUIN
Germany
Germany
Germany
Germany
Germany
Germany
Germany
YAO, LEI
2017-07-2615546609HUMAN NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (hNGAL) MUTEINS CAPABLE OF BINDING ANGIOPOIETIN-2 (ANG-2) AND METHODS OF USE THEREOFPieris Pharmaceuticals GmbHPatented Case2020-01-0710526382US20180016312A1
Rachida Siham BEL AIBA
Andrea ALLERSDORFER
Alexander WIEDENMANN
Christine ROTHE
Shane OLWILL
Hendrik GILLE
Laurent Audoly
Germany
Germany
Germany
Germany
Germany
Germany
France
LANDSMAN, ROBERT S
2016-12-1515380168MUTEINS OF HUMAN LIPOCALIN 2 (LCN2,HNGAL) WITH AFFINITY FOR A GIVEN TARGETPieris Pharmaceuticals GmbHPatented Case2020-04-1410618941US20170114109A1
ARNE SKERRA
Michaela GEBAUER
Dominik HINZ
Sabine RAUTH
Gabriele MATSCHINER
Martin HUELSMEYER
Germany
Germany
Germany
Germany
Germany
Germany
EPPS-SMITH, JANET L
2016-12-0715371698NOVEL PROTEINS SPECIFIC FOR CALCITONIN GENE-RELATED PEPTIDEPIERIS PHARMACEUTICALS GMBHPatented Case2019-09-0310400016US20170166615A1
GABRIELE MATSCHINER
Christine ROTHE
Alexander WIEDENMANN
Rachida Siham BEL AIBA
Marlon HINNER
Andrea ALLERSDORFER
Bradley LUNDE
Kazufumi KUBOTA
Mitsuhiro MAKINO
Sakiko TAKAHASHI
Ryuji HASHIMOTO
Tohru TAKAHASHI
Mamoru OTOYO
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Japan
Japan
Japan
Japan
Japan
Japan
LIEB, JEANETTE M
2015-05-1414442924NOVEL INTERLEUKIN-17A-SPECIFIC AND INTERLEUKIN-23-SPECIFIC BINDING POLYPEPTIDES AND USES THEREOFPIERIS PHARMACEUTICALS GMBHPatented Case2020-01-0710526384US20150344538A1
Marlon HINNER
Laurent AUDOLY
Martin HUELSMEYER
Kristian JENSEN
Gabriele MATSCHINER
Shane OLWILL
Alexander WIEDENMANN
Andrea ALLERSDORFER
Germany
France
Germany
Austria
Germany
Germany
Germany
Germany
JIANG, DONG
2014-06-2714369353METHODS AND COMPOSITIONS FOR TREATING DISORDERSPIERIS PHARMACEUTICALS GMBHPatented Case2018-09-0410064963US20150004098A1
Shane Olwill
Hendrik Gille
Laurent Audoly
Marlon Hinner
Elisabeth De Vries
Anton G.T. Terwisscha Van Scheltinga
Germany
Germany
United States
Germany
Netherlands
Netherlands
JONES, DAMERON LEVEST

Similar stocks

Stock NameCountryMarket CapPE Ratio
Braveheart Bio, Inc. (BRVE)United States$2.106B
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Generate Biomedicines, Inc. (GENB)United States$2.052B
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12